← Leaderboards
Mokenge P. Malafa
H. Lee Moffitt Cancer Ctr & Res Inst
$4,250,080
Attributed
$5,276,204
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $710.2K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,276,204 · 2
By mechanism
R01$5,276,204 · 2
Top collaborators
- Surinder Kumar Batra4 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Gary W Reuther$4,321,756
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMicronutrientsMalignant NeoplasmsPancreatic NeoplasmPreventInsightPancreasMolecularSerumMalignant Neoplasm Of PancreasCancer CellMutationNeoplastic CellOncogenicPreventionDelta TocotrienolPhysiologicalChemopreventive AgentPathway InteractionsCell ProliferationBiochemicalApoptosisSafetySignal Transduction
Grant awards (9)
Novel Therapy to Inhibit IPMN Progression$635,784
R01 · FY2024 · CA · contact PI
Novel Therapy to Inhibit IPMN Progression$74,401
R01 · FY2024 · CA · contact PI
Novel Therapy to Inhibit IPMN Progression$655,860
R01 · FY2023 · CA · contact PI
Novel Therapy to Inhibit IPMN Progression$686,204
R01 · FY2022 · CA · contact PI
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol$606,121
R01 · FY2012 · CA · contact PI
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol$629,096
R01 · FY2011 · CA · contact PI
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol$656,718
R01 · FY2010 · CA · contact PI
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol$677,025
R01 · FY2009 · CA · contact PI
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol$654,995
R01 · FY2008 · CA · contact PI